Opposite β2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity

Biochimica et Biophysica Acta - Biomembranes

Volumn 1416, Issue 1-2, 1999, Pages 225-238

  Celli, Claudia Maria ^a,c   Gharavi, Azzudin E ^b   Chaimovich, Hernan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

2 Glycoprotein I; Antiphospholipid antibody; Autoimmune disease; Cardiolipin; Liposome leakage; Syphilis

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN; EPITOPE; PHOSPHOLIPID ANTIBODY; 6 CARBOXYFLUORESCEIN; 6-CARBOXYFLUORESCEIN; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; GLYCOPROTEIN; IMMUNOGLOBULIN G; LIPOSOME;

ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFECTION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; ANTIBODY AFFINITY; BLOOD; CHEMISTRY; IMMUNOLOGY; PERMEABILITY; SYPHILIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY AFFINITY; AUTOIMMUNE DISEASES; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; EPITOPES; FLUORESCEINS; FLUORESCENT DYES; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LIPOSOMES; PERMEABILITY; SYPHILIS;

EID: 0033547710     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(98)00225-9     Document Type: Article

References (68)

1. E.N. Harris, A.E. Gharavi, M.L. Boey, B.M. Patel, C.G. Mackworth-Young, S. Loizou, G.R.V. Hughes, Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus, Lancet 2 (1983) 1211-1214.
2. G.R.V. Hughes, Thrombosis, abortion, cerebral disease, and the lupus anticoagulant, Br. Med. J. 287 (1983) 1088-1089.
3. P.B. Costello, F.A. Green, Reactivity patterns of human anticardiolipin and other antiphospholipid antibodies in syphilitic sera, Infect. Immun. 51 (1986) 771-775.
4. R.T. Canoso, H.S. Sise, Chlorpromazine induced lupus anticoagulant and associated immunologic abnormalities, Am. J. Haematol. 13 (1982) 121-129.
5. M.H. Zarrabi, S. Zucker, F. Miller, Immunologic and coagulation disorders in chlorpromazine treated patients, Ann. Intern. Med. 91 (1979) 195-199.
6. M.L. Boey, C.B. Colaco, G.R.V. Gharavi, K.B. Elkon, S. Loizou, G.R.V. Hughes, Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant, Br. Med. J. 287 (1983) 1021-1023.
7. E.N. Harris, R.A. Asherson, A.E. Gharavi, S.H. Morgan, G. Derue, G.R.V. Hughes, Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodies, Br. J. Haematol. 59 (1985) 227-230.
8. M.D. Lockshin, M. Druzin, S. Goei, T. Qamar, M. Magid, L. Janovic, M. Ferenc, Antibody to cardiolipin as a predictor to fetal death in pregnant patients with systemic lupus erythematosus, N. Engl. J. Med. 313 (1985) 152-156.
9. T. Qamar, R.A. Levy, L.R. Sammaritano, A.E. Gharavi, M.D. Lockshin, Characteristics of high-liter IgG antiphospholipid antibody in systemic lupus erythematosus with and without fetal death, Arthritis Rheum. 33 (1990) 501-504.
10. J. Pietro, J.R. Yustre, O. Beloqui, M.P. Civeira, J.I. Riezu, B. Aguirre, B. Sangro, Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome, Hepatology 23 (1996) 199-204.
11. J. Matsuda, N. Saitoh, M. Gotoh, K. Gohchi, M. Tsukamoto, S. Syoji, K. Miyake, M. Yamanaka, High prevalence of antiphospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-α, Am. J. Gastroenterol. 90 (1995) 1138-1141.
12. S.S. Pierangeli, G.H. Goldsmith, S. Krnic, E.N. Harris, Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome, Infect. Immun. 62 (1994) 4081-4084.
13. E.N. Harris, A.E. Gharavi, S.P. Patel, G.R.V. Hughes, Evaluation of the anticardiolipin antibody test: report of a standardization workshop held 4 April 1986, Clin. Exp. Immunol. 68 (1987) 215-222.
14. A.E. Gharavi, E.N. Harris, R.A. Asherson, G.R.V. Hughes, Anticardiolipin antibodies, isotype distribution and phospholipid specificity, Ann. Rheum. Dis. 46 (1987) 1-6.
15. S. Loizou, J.D. McCrea, A.C. Rudge, R. Reynolds, C.C. Boyle, E.N. Harris, Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantification of results, Clin. Exp. Immunol. 62 (1985) 738-745.
16. 2-glycoprotein I (apolipoprotein H), Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4120-4124.
17. M. Galli, P. Comfurius, C. Maasen, H.C. Hemker, M.H. DeBaets, P.J.C. Van Breda-Vriesman, T. Barbui, R.F.A. Zwaal, E.M. Bevers, Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor, Lancet 335 (1990) 1544-1547.
18. R.A.S. Roubey, Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies, Blood 84 (1994) 2854-2867.
19. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface, J. Exp. Med. 179 (1994) 457-462.
20. E. Matsuura, Y. Igarashi, M. Fujimoto, K. Ichikawa, T. Koike, Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease, Lancet 336 (1990) 177-178.
21. L.W. Chamley, E.J. McKay, N.S. Pattison, Cofactor dependent and cofactor independent anticardiolipin antibodies, Thromb. Res. 61 (1991) 291-299.
22. 2GPI) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies, Br. J. Haematol. 82 (1992) 565-570.
23. 2-glycoprotein I and human immunoglobulin G antiphospholipid antibodies, Circulation 94 (1996) 1746-1751.
24. J. Rauch, A.S. Janoff, Antibodies against phospholipids other than cardiolipin: potential roles for both phospholipid and protein, Lupus 5 (1996) 498-502.
25. B.G. Schuster, B.M. Neidig, B.M. Alving, C.R. Alving, Production of antibodies against phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A, J. Immunol. 122 (1979) 900-905.
26. B. Banerji, J.A. Lyon, C.R. Alving, Membrane lipid composition modulates the binding specificity of a monoclonal antibody against liposomes, Biochim. Biophys. Acta 689 (1982) 319-326.
27. 2-glycoprotein I (apolipoprotein H), J. Clin. Invest. 90 (1992) 1105-1109.
28. 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies, J. Immunol. 155 (1995) 958-966.
29. 2-glycoprotein I or anticardiolipin antibodies alone, Clin. Exp. Immunol. 93 (1993) 269-272.
30. 2GPI, Am. J. Reprod. Immunol. 37 (1997) 118-124.
31. S. Mouritsen, M. Hoier-Madsen, A. Wiik, O. Orum, N.S. Pedersen, The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus, Clin. Exp. Immunol. 76 (1989) 178-183.
32. E.N. Harris, A.E. Gharavi, G.D. Wasley, G.R.V. Hughes, Use of an enzyme-linked immunosorbent assay and inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders, J. Infect. Dis. 157 (1988) 3-31.
33. E. Matsuura, M. Igarashi, M. Fujimoto, K. Ichikawa, T. Suziki, T. Sumida, T. Yasuda, T. Koike, Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor, J. Immunol. 148 (1992) 3885.
34. R.A. Levy, A.E. Gharavi, L.R. Sammaritano, L. Habina, T. Qamar, M.D. Lockshin, Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis, J. Rheumatol. 17 (1990) 1036-1041.
35. 2-glycoprotein I to human serum lipoproteins: distribution among density fractions, FEBS Lett. 102 (1979) 183-186.
36. 2-glycoprotein I to platelets. Effect of adenylate cyclase activity, Thromb. Res. 19 (1980) 225-237.
37. 2-glycoprotein I (apolipoprotein H) interactions with phospholipid vesicles, Int. J. Biochem. 16 (1984) 511-515.
38. 2-glycoprotein I, Biochim. Biophys. Acta 884 (1986) 142-149.
39. J. Nimpf, H. Wurm, G.M. Kostner, Beta 2-glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation, Atherosclerosis 63 (1987) 109-111.
40. I. Schousboe, In vitro activation of the contact activation system (Hageman factor system) in plasma by acidic phospholipids and the inhibitory effect of beta-2-glycoprotein I in this activation, Int. J. Biochem. 20 (1988) 309-315.
41. 2-glycoprotein I, Br. J. Haematol. 87 (1994) 548-554.
42. M.D. Smirnov, D.A. Triplett, P.C. Comp, N.L. Esmon, C.T. Esmon, On the role of phosphatidylethanolamine in the inhibition of protein C activity by antiphospholipid antibodies, J. Clin. Invest. 95 (1995) 309-316.
43. 2-glycoprotein I is a major protein associated with a very rapidly cleared liposomes in vivo suggesting a significant role in the immune clearance of non-self particles, J. Biol. Chem. 270 (1995) 25845.
44. C.R. Alving, Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens, Biochim. Biophys. Acta 1113 (1992) 307-322.
45. M.P.D. Gremião, C.M. Celli, H. Chaimovich, Anticardiolipin antibodies from syphilis and systemic lupus erythematosus induce leakage in cardiolipin-phosphatidylcholine vesicles, Brazil. J. Med. Biol. Res. 29 (1996) 489-494.
46. D.N. Rodes, C.H. Lea, Phospholipids on the composition of hen's egg phospholipids, Biochem. J. 65 (1957) 526-529.
47. L.P. Lelkes, Methodological aspects dealing with stability measurements of liposomes in vitro using carboxyfluorescein assay, in: G. Gregoriades (Ed.), Liposome Technology, vol. 3, CRC Press, Boca Raton, FL, 1983, pp. 225-245.
48. L.R. Sammaritano, M.D. Lockshin, A.E. Gharavi, Antiphospholipid antibodies differ in aPL cofactor requirement, Lupus 1 (1992) 83-90.
49. E. Polz, H. Wurm, G.M. Kostner, Investigations on beta-2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fractions, Int. J. Biochem. 11 (1980) 265-270.
50. R.E. Morton, I. Evans, Modification of the bicinchoninic acid and protein assay to eliminate lipid interference in determining protein content, Anal. Biochem. 204 (1992) 332-334.
51. A.E. Gharavi, H. Reiber, Affinity and avidity of autoantibodies, in: J.B. Peter, Y. Shoenfeld (Eds.), Autoantibodies, Elsevier Science, New York, 1996, pp. 13-23.
52. M.W. Steward, A.M. Lew, The importance of antibody affinity in the performance of immunoassays for antibody, J. Immunol. Methods 78 (1985) 173-190.
53. G. Rouser, S. Fleisher, A. Yamamoto, Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots, Lipids 5 (1970) 494-496.
54. M.S. Baptista, I. Cuccovia, H. Chaimovich, M.J. Politi, W.F. Reed, Electrostatic properties of zwitterionic micelles, J. Phys. Chem. 96 (1992) 6442-6449.
55. F. Bonté, R.L. Juliano, Interaction of liposomes with serum proteins, Chem. Phys. Lipids 40 (1986) 359-372.
56. S. Ohki, E. Marcus, D.K. Sukumaran, K. Arnold, Interaction of melittin with lipid membranes, Biochim. Biophys. Acta 1194 (1994) 223-232.
57. 2-glycoprotein I is bound to a suitable surface, Thromb. Haemost. 13 (1995) 29-34.
58. M.E. Goldberg, L. Djvadi-Ohaniance, Methods for measurement of antibody/antigen affinity based on ELISA and RIA, Curr. Opin. Immunol. 5 (1993) 278-281.
59. 2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune diseases, Lupus 4 (1995) 477-481.
60. M. Laakel, M. Bouchacrd, J. Lagacè, Measurement of mouse anti-phospholipid antibodies to solid-phase microspheres by both flow cytofluorometry and Alcian blue-pretreated microtitre plates in an ELISA, J. Immunol. Methods 190 (1996) 267-273.
61. V. Eschwège, I. Laude, F. Toti, J.L. Pasquali, J.M. Freyssinet, Detection of bilayer phospholipid-binding antibodies using flow cytometry, Clin. Exp. Immunol. 103 (1996) 171-175.
62. M.D. Lockshin, T. Qamar, R.A. Levy, M.P. Best, IgG but not IgM antiphospholipid antibody binding is temperature dependent, J. Clin. Immunol. 8 (1988) 188-192.
63. M. Caffrey, J. Hogan, LIPIDAT: a database of lipid phase transition temperatures and enthalpy changes. DMPC data subset analysis, Chem. Phys. Lipids 62 (1992) 1-109.
64. C.R. Alving, Antibodies to liposomes, phospholipids and phosphate esters, Chem. Phys. Lipids 40 (1986) 303-314.
65. F. Martini, A. Farsi, A.M. Gori, M. Boddi, S. Fedi, M.P. Domeneghetti, A. Passaleva, D. Prisco, R. Abbate, Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus, Lupus 5 (1996) 206-211.
66. R. Simantov, J.M. LaSala, S.K. Lo, A.E. Gharavi, L.R. Sammaritano, J.E. Salmon, R.L. Silverstein, Activation of cultured vascular endothelial cells by antiphospholipid antibodies, J. Clin. Invest. 96 (1995) 2211-2219.
67. 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences between lupus anticoagulant, Blood 81 (1993) 1255-1262.
68. 2-glycoprotein I-dependent manner, J. Immunol. 157 (1996) 2201-2208.